H. Lundbeck A/S
OOTC:HLUYYCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- Address
- Similar Companies
- Business
Company News
H. Lundbeck A/S (OTCMKTS:HLUYY) & FIH Mobile (OTCMKTS:FXCNY) Financial Survey
Lundbeck's Appreciation Potential Is Closely Tied To A High-Risk Clinical Pipeline (Rating Upgrade)
Longboard Pharmaceuticals' stock soars amid Lundbeck's $2.6 billion deal to acquire the company
Lundbeck On A Better Path, But With Some Risks
Lundbeck to Present Broad Range of Data on Migraine and Brain Health at 75th Annual Meeting of the American Academy of Neurology
Otsuka Pharmaceutical and Lundbeck to Present Phase 3 Data for Brexpiprazole in Patients with Alzheimer's Dementia at AAIC 2022
H Lundbeck AS (HLUYY) Surges 12.5%: Is This an Indication of Further Gains?
H. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q4 2021 Results - Earnings Call Transcript
H. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q3 2021 Results - Earnings Call Transcript
H. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q2 2021 Results - Earnings Call Transcript